Concord Biotech
Concord Biotech
  • About Us
    • Vision & Mission
    • Global Presence
    • Evolution
    • Leadership
  • R & D
    • API
      • Biotechnology
      • Chemical
    • Formulation
      • Formulation Development
  • Facilities
    • API
    • Formulation
  • Accreditation
    • API
    • Formulation
  • Products
    • API
      • Products
      • Contract Research & Manufacturing
    • Formulation
      • Regulated Markets
      • Emerging Markets
      • Contract Research & Manufacturing
    • India Formulation
      • Critical Care
      • Nephrology
  • Investors
  • CSR
  • Career
    • API Unit 1
    • Formulation Unit 2
    • API Unit 3
    • Sales & Marketing / Corporate
  • News
  • More+
    • Contact Us
    • Blog

INVESTORS

ANNUAL REPORT

Annual Report – Concord Biotech Limited

Annual Report : FY19-20

Annual Report : FY20-21

Annual Report : FY21-22

JOINT VENTURE FINANCIAL INFORMATION

Joint Venture Financial Information

MATERIAL CREDITORS

Material Creditors

POLICIES

Insider Trading Policy

Dividend Distribution Policy

Code of Practises – Fair Disclosure of UPSI

Code of Conduct for BoD and SMPs

Archival Policy

Policy For Determination Of Materiality

Whistle Blower Policy

UPSI Leak Inquiry Policy

Succession Policy

Risk Management Policy

Policy to promote Diversity of Board of Directors

Policy on Related Party Transactions

Policy on Material Subsidiaries

Policy for Preservation of Documents

Policy for Familiarisation Programme for Independent Directors

Policy For Evaluation Of The Performance Of The Board Of Directors

Nomination and Remuneration Policy

QUICK LINKS

  • Home
  • About Us
  • Global Presence
  • Evolution
  • CSR

BUSINESSES

  • Products
  • R&D
  • Facilities
  • Accreditations

GET IN TOUCH

  • News & Media
  • Career
  • Contact Us

Copyright © 2023 Concord Biotech. All rights reserved.